Abstract
Overview
Introduction
Based on an analysis of 43 companies and 1,200+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 3.2% CAGR 2006 to 2012. However, behind this industry average figure there are strategic segments of the market that offer double-digit growth rates through barriers against generic competition and the opportunity for aggressive indication broadening.
Scope of this report
- Strategic Analysis of the Sales Outlook to 2012 for Big Pharma, Mid Pharma, Japan Pharma and Biotech
- Quantitative analysis of the revenue balance of launches and expiries for each peer set member to 2012
- Assessment of current and forecast 2012 therapy area sales and molecule type focus for each peer set member
Research and analysis highlights
Faced with failing growth, Big Pharma is expected to pursue strategic options including operational cost efficiencies, M&A with other Big Pharma companies, biotech, Mid Pharma CNS players and/or generics manufacturers and acquisitional moves outside of ' pharma space' to increase presence in medical devices, diagnostics and consumer healthcare.
Key reasons to read this report
- Understand the strategic motives behind the recent wave of Big Pharma acquisitions of monoclonal antibody companies
- Identify the rare examples of promising high growth CNS products located in the Mid Pharma peer set
- Learn how biotech faces slowing growth momentum due to commercial pressures on therapeutic proteins
Table of Contents
- Overview
- Catalyst
- Summary
- Executive Summary
- Analysis
- Action
- Table of Contents
- Analysis
- TREND: Media consumption is rising
- TREND: We are reaching a tipping point after which traditional TV viewing will decline
- TREND: Marketing expenditure is following media consumption
- INSIGHT: Traditional media remain important
- INSIGHT: People and families use online to improve their lives
- INSIGHT: New media requires different skills
- Take-outs and implications
- Actions
- Keep your Web 1.0 presence refreshed
- Take-outs and implications
- Experiment with Web 2.0
- Establish conversations with consumers
- Tap into the demand for media sharing
- Trial social advertising
- Marketing on Facebook
- Monitor marketing via mobile devices
- Take-outs and implications
- Conclusions
- Keep your Web 1.0 presence refreshed
- APPENDIX
- Additional data
- Methodology
- Further reading
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- List of Tables
- Table 1: European media consumption by main type, 2004-06
- Table 2: Media consumption by main type, US vs Europe
- Table 3: TV viewing per household by country
- Table 4: Consumer motivations for visiting a CPG website, 2007
- Table 5: Share of US population that uses social networking sites by age group
- List of Figures
- Figure 1: Mr Clean Bathroom Explorer is a web-based tool that helps users choose the best cleaner for a job
- Figure 2: Health Expressions is a P&G site that contains a range of health information
- Figure 3: The Bud Bucks website allows consumers to spend the currency they have earned sending text messages using codes from Budweiser bottles and cans
- Figure 4: Unilever has established a presence on virtual reality site Second Life via its ck IN2U brand
- Figure 5: Artofthecookie is designed to help women improve their social lives
- Figure 6: Capessa is a website designed for women to discuss issues that interest them and submit personal stories
- Figure 7: Buckley' s on MySpace utilizes user-generated content by encouraging consumers to submit photos of themselves tasting the product
- Figure 8: Bud.tv is an online entertainment website with seven channels
- Figure 9: Annual hours worked per person, selected industrialized economies, 1990-2002
- Figure 10: Internet usage is highest in Asia, though penetration is highest in North America
- Figure 11: Mobile phone penetration is highest in Europe, followed by North America and Asia-Pacific
